Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis

A large number of clinical studies have shown that oral administration, external application or enema of Chinese medicine can promote the recovery of gastrointestinal function and the absorption of pancreatic inflammation. The aims of the study is to explore the application of Dachaihu Decoction Compound (DDC)and Rhubarb Single Medicine (RSM) in the Treatment of Acute Pancreatitis.

Not Yet Recruiting

Trial opening soon.

Get Notified

Key information

Conditions

Acute Pancreatitis Digestive System Diseases Pancreatic Diseases Pancreatitis

Age range

18 year–65 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Age from 18 to 65 years old
Meet the diagnostic criteria of western medicine for acute pancreatitis, within 48 hours of onset
Consent of the subjects, who sign the informed consent form

Exclusion criteria

Women who are pregnant or breastfeeding
Acute abdomen such as organic intestinal obstruction, gastrointestinal perforation, purulent cholangitis, etc.
Patients with a history of severe heart, liver, kidney and other important organ diseases
Patients with mental illness and malignant tumors
People who have allergies, or are allergic to a certain drug ingredient

Treatment and study plan

Dachaihu decoction compound

Combination Product

Dachaihu decoction compound includes Bupleurum, Rhubarb, Citrus aurantium, Scutellaria, Pinellia, White Peony, Jujube, Ginger.

Rhubarb single medicine

Drug

Rhubarb single medicine

Regular therapies

Combination Product

Regular therapies, such as fluid therapy, for acute pancreatitis

Primary outcomes

Significant and effective rate

Time frame: 7 days

Significant and effective rate after 7 days of treatment

Sponsors and collaborators

Lead sponsor

Fifth Affiliated Hospital, Sun Yat-Sen University

Other

Registry information

Official study title

Comparison of Clinical Efficacy of Dachaihu Decoction Compound and Rhubarb Single Medicine in the Treatment of Acute Pancreatitis

Important dates

Study start: 2023
Primary completion: 2029
Study completion: 2029
First posted: Aug 4, 2021
Registry last updated: Mar 24, 2022

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.

Not Yet Recruiting